| For: | Yoon JH, Jung YJ, Moon SH. Immunotherapy for pancreatic cancer. World J Clin Cases 2021; 9(13): 2969-2982 [PMID: 33969083 DOI: 10.12998/wjcc.v9.i13.2969] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i13/2969.htm |
| Number | Citing Articles |
| 1 |
Craig Grobbelaar, Mpho Kgomo, Peace Mabeta. Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome
Treatment Resistance. Current Cancer Drug Targets 2024; 24(11) doi: 10.2174/0115680096284588240105051402
|
| 2 |
Udit Basak, Sumon Mukherjee, Sourio Chakraborty, Gaurisankar Sa, Shubhra Ghosh Dastidar, Tanya Das. In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-93924-3
|
| 3 |
Danielle O'Meara, Clare Hoskins. Developments & Potential of Nanotechnology for the Detection and Treatment of Pancreatic Cancer. International Journal of Nanomedicine 2026; doi: 10.2147/IJN.S559038
|
| 4 |
Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, Jade Gambill, Diksha Mahendru, Chandler H. Park, Yan Leyfman. Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian. Cancers 2024; 16(13) doi: 10.3390/cancers16132329
|
| 5 |
Julian Burks, Shweta Tiwary, David M Stevens, Sarah L Skoczen, Ruvanthi N Kularatne, Stephan T Stern, Jay A Berzofsky. PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumors. Journal for ImmunoTherapy of Cancer 2025; 13(3) doi: 10.1136/jitc-2024-009539
|
| 6 |
Simone Donati, Cinzia Aurilia, Gaia Palmini, Irene Falsetti, Teresa Iantomasi, Maria Luisa Brandi. Autophagy-Related ncRNAs in Pancreatic Cancer. Pharmaceuticals 2022; 15(12) doi: 10.3390/ph15121547
|
| 7 |
Xiuli Xia, Shushan Zhao, Xiaoming Song, Mengyue Zhang, Xinying Zhu, Changjuan Li, Wenting Chen, Dongqiang Zhao. The potential use and experimental validation of genomic instability-related lncRNA in pancreatic carcinoma. Medicine 2023; 102(37) doi: 10.1097/MD.0000000000035300
|
| 8 |
Monica Argenziano, Chiara Monge, Anna Scomparin, Francesco Trotta, Valentina Boscaro, Casimiro Luca Gigliotti, Ian Stoppa, Umberto Dianzani, Stefania Pizzimenti, Roberta Cavalli, Chiara Dianzani. Gemcitabine-loaded ICOS-Fc decorated nanosponges: A new chemo immunotherapy combination against pancreatic cancer. International Journal of Pharmaceutics 2025; 682 doi: 10.1016/j.ijpharm.2025.125869
|
| 9 |
Yun Kong, Jing Zhao, Beihua Xu, Xiaoyue Yang, Lingjie Zhang, Jin Tao, Ying Hu. Construction and synergistic effect of a CGT-Cls-PTX/CM nanocodelivery system targeting the tumor microenvironment. Nanotechnology 2026; 37(5) doi: 10.1088/1361-6528/ae39e3
|
| 10 |
Murtaza Ahmed, Brent K. Larson, Arsen Osipov, Nilofer Azad, Andrew Hendifar. A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. Oncotarget 2024; 15(1) doi: 10.18632/oncotarget.28659
|
| 11 |
Angela Lauriola, Pierpaola Davalli, Gaetano Marverti, Spartaco Santi, Andrea Caporali, Domenico D’Arca. Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy. Cancers 2023; 15(11) doi: 10.3390/cancers15113009
|
| 12 |
思博 陈. Research Progress of Immunotherapy for Pancreatic Malignant Tumors. World Journal of Cancer Research 2025; 15(02) doi: 10.12677/wjcr.2025.152008
|
| 13 |
Léon Raymakers, Elsemieke M. Passchier, Meggy E. L. Verdonschot, Mitchell Evers, Chilam Chan, Karel C. Kuijpers, G. Mihaela Raicu, I. Quintus Molenaar, Hjalmar C. van Santvoort, Karin Strijbis, Martijn P. W. Intven, Lois A. Daamen, Jeanette H. W. Leusen, Patricia A. Olofsen. The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma. Cells 2025; 14(9) doi: 10.3390/cells14090632
|
| 14 |
Dylan Thomas, Priya Bharadwa, Timothy Lee, Carolina S. Ilkow. A framework for the rational design of oncolytic viruses: A holistic perspective considering the tumour microenvironment. Seminars in Immunology 2025; 79 doi: 10.1016/j.smim.2025.101977
|
| 15 |
Chao Yin, Ali Alqahtani, Marcus S. Noel. The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways. Cancers 2022; 14(11) doi: 10.3390/cancers14112619
|
| 16 |
Cheng Yan, Yandie Niu, Feng Li, Wei Zhao, Liukai Ma. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03632-z
|
| 17 |
Yonghao Xu, Yisu Wang, Qi Chen, Tao Yao, Junyu Qiu, Lei Ni, Hui Chen, Tingbo Liang. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation. Pancreatology 2023; 23(8) doi: 10.1016/j.pan.2023.10.021
|
| 18 |
Manoj Kumar Gupta, Ramakrishna Vadde. Immune Landscape of Pancreatic Cancer Development and Drug Resistance. 2024; doi: 10.1016/B978-0-443-23523-8.00004-3
|
| 19 |
Thomas Lambin, Cyril Lafon, Robert Andrew Drainville, Mathieu Pioche, Frédéric Prat. Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma. World Journal of Gastroenterology 2022; 28(13): 1288-1303 doi: 10.3748/wjg.v28.i13.1288
|
| 20 |
Shiyu Liu, Fan Li, Li Deng, Qiongqiong Ma, Wenyi Lu, Zhuoqian Zhao, Huanzhen Liu, Yixuan Zhou, Manli Hu, Hui Wang, Yingbin Yan, Mingfeng Zhao, Hongkai Zhang, Mingjuan Du. Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. Molecular Therapy - Oncolytics 2023; 30 doi: 10.1016/j.omto.2023.08.011
|
| 21 |
Sakarie Mustafe Hidig, Muhammad Umer Farooq Mujahid, Fidele Kakule Kitaghenda, Zhenhua Hu. Advancing Therapeutic Strategies for Pancreatic Cancer: A Review of Surgical, Systemic and Diagnostic Innovations. Bratislava Medical Journal 2025; 127(1) doi: 10.1007/s44411-025-00460-7
|
| 22 |
Xinyao Sun, Qi Yang, Lele Song, Youlan Lei, Wenpeng Huang, Zhao Chen, Yongkang Qiu, Lei Kang, Tianyao Wang. ImmunoPET imaging of c-Met using a nanobody-based tracer [68Ga]Ga-NOTA-PFCM01 in pancreatic ductal adenocarcinoma models and non-human primates. European Journal of Nuclear Medicine and Molecular Imaging 2025; 53(1) doi: 10.1007/s00259-025-07441-6
|
| 23 |
Yanyan Kong, Fang Xie, Zhengwei Zhang, Shaobo Wang, Yabin Zhang, Yang Di, Zhongwen Zhou, Donglang Jiang, Junpeng Li, Qi Huang, Jie Wang, Xiuming Li, Zhiwei Pan, Ruiqing Ni, Yihui Guan. Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma. European Radiology 2023; 33(10) doi: 10.1007/s00330-023-09679-w
|
| 24 |
Zouina Sarfraz, Azza Sarfraz, Muhammad Danyal Farooq, Musfira Khalid, Khadija Cheema, Faheem Javad, Taleah Khan, Zainab Pervaiz, Muzna Sarfraz, Ali Jaan, Subhan Sadiq, Junaid Anwar. The Current Landscape of Clinical Trials for Immunotherapy in Pancreatic Cancer: A State-of-the-Art Review. Journal of Gastrointestinal Cancer 2024; 55(3) doi: 10.1007/s12029-024-01078-8
|
| 25 |
Xiao Xu, Xiang Wang, Yu-Pei Liao, Lijia Luo, Andre E. Nel. Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA. ACS Nano 2025; 19(9) doi: 10.1021/acsnano.4c14102
|
| 26 |
Yiming Shao, Rui Hao, Si Si Lin, Ba-Fang Ma, Jun-Nan Ye, Mayila Maimaiti, Yasen Maimaitiyiming. HDL Cholesterol Levels and Pancreatic Cancer Risk: Protective Effects Revealed. Current Cancer Drug Targets 2026; 26(2) doi: 10.2174/0115680096334509241218141459
|
| 27 |
Belén Toledo, Chiara Deiana, Fabio Scianò, Giovanni Brandi, Juan Antonio Marchal, Macarena Perán, Elisa Giovannetti. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives. Expert Review of Clinical Pharmacology 2024; 17(4) doi: 10.1080/17512433.2024.2319340
|
| 28 |
Ayesha Aslam, Hafsa Hamid, Eman Fatima, Sumaira Pervaiz, Mehnaz Arif, Huda Irshad, Amina Shafqat, Sara Khan, Huma Khurshid, Saira Rafaqat. Inflammatory biomarkers in the pathogenesis of pancreatic cancer: A literature review. World Journal of Clinical Oncology 2025; 16(10): 109385 doi: 10.5306/wjco.v16.i10.109385
|
| 29 |
Sherin Shaji, Pratikkumar Patel, Umar-Farouk Mamani, Yuhan Guo, Sushil Koirala, Chien-Yu Lin, Mohammed Alahmari, Evanthia Omoscharka, Kun Cheng. Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth. International Journal of Nanomedicine 2024; doi: 10.2147/IJN.S462213
|
| 30 |
Hiromichi Sato, Tomoaki Hara, Sikun Meng, Yoshiko Tsuji, Yasuko Arao, Yoshiko Saito, Kazuki Sasaki, Shogo Kobayashi, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii. Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: Current understanding and future directions. Cancer Science 2023; 114(9) doi: 10.1111/cas.15890
|
| 31 |
Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda. A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way. European Journal of Pharmacology 2024; 969 doi: 10.1016/j.ejphar.2024.176451
|
| 32 |
Ashley L. Kiemen, Valentina Matos, Cristina Almagro-Pérez, André Forjaz, Alicia M. Braxton Hickman, Lucie Dequiedt, Jeeun Parksong, Courtney D. Cannon, Xuan Yuan, Sarah M. Shin, Jaanvi Mahesh Babu, Elizabeth D. Thompson, Toby C. Cornish, Won Jin Ho, Laura D. Wood, Pei-Hsun Wu, Arrate Muñoz Barrutia, Ralph H. Hruban, Denis Wirtz. Quantitative 3D histology reveals localized immune remodeling during early pancreatic cancer progression. Cell Press Blue 2026; 1(2) doi: 10.1016/j.cpblue.2026.100008
|
| 33 |
Xiangying Deng, Xu He, Zehua Yang, Jing Huang, Lin Zhao, Min Wen, Xiyuan Hu, Zizheng Zou. Clustering analysis and prognostic model based on PI3K/AKT-related genes in pancreatic cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1112104
|
| 34 |
Ling-Jen Hung, Chen-Yang Huang, Kai-Che Tung, Jen-Shi Chen, Wen-Kuan Huang, Chih-Chung Hsu, Yueh-Fu Fang, Chih-Liang Wang, Ping-Chi Liu, Kun-Yun Yeh, Pei-Hung Chang, John Wen-Cheng Chang, Yung-Chang Lin, Shiu-Feng Huang, Wen-Chi Chou. Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts. Journal of the Formosan Medical Association 2025; 124(9) doi: 10.1016/j.jfma.2024.09.001
|
| 35 |
Imke Stouten, Nadine van Montfoort, Lukas J. A. C. Hawinkels. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(10) doi: 10.3390/ijms24108707
|
| 36 |
Gerald Batist, Petr Kavan, Lance Augustin, Janet Schottel, Jordan Moradian, James T. Lee, Daniel Saltzman. A phase 2 study of orally administered live biotherapeutic salmonella-IL2 with FOLFIRINOX for stage IV pancreatic cancer. Cancer Immunology, Immunotherapy 2026; 75(2) doi: 10.1007/s00262-026-04307-0
|
| 37 |
Ana Bogut, Bojan Stojanovic, Marina Jovanovic, Milica Dimitrijevic Stojanovic, Nevena Gajovic, Bojana S. Stojanovic, Goran Balovic, Milan Jovanovic, Aleksandar Lazovic, Milos Mirovic, Milena Jurisevic, Ivan Jovanovic, Violeta Mladenovic. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. International Journal of Molecular Sciences 2023; 24(21) doi: 10.3390/ijms242115500
|
| 38 |
Wei Wang, Sujing Zhang, Cong Wang, Siming Gao, Lingling Zhang, Changwang Zhang, Zheng Zheng, Jiancong Zhang, Hui Xu, Changwen Bo, Na Li. Fluorouracil enhances the anti-pancreatic cancer effect of anti-PD-L1 antibodies via up-regulating the expression of PD-L1 in cancer cells. Journal of Investigative Medicine 2025; 73(3) doi: 10.1177/10815589251314192
|
| 39 |
Frederik J. Hansen, Paul David, Marina Akram, Samuel Knoedler, Anke Mittelstädt, Susanne Merkel, Malgorzata J. Podolska, Izabela Swierzy, Lotta Roßdeutsch, Bettina Klösch, Dina Kouhestani, Anna Anthuber, Alan Bénard, Maximilian Brunner, Christian Krautz, Robert Grützmann, Georg F. Weber. Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients. Cancers 2023; 15(2) doi: 10.3390/cancers15020363
|
| 40 |
Xiangjun Wang, Chuanxin Yang, Yangming Liu, Jian Wang. SUMOylation substrate encoding genes as prognostic biomarkers in pancreatic ductal adenocarcinoma with functional assessment of SAF-B2. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1532658
|
| 41 |
Amna Khalid, Sarfraz Ahmad. Immune Landscape of Pancreatic Cancer Development and Drug Resistance. 2024; doi: 10.1016/B978-0-443-23523-8.00011-0
|
| 42 |
Saira Rafaqat, Huma Khurshid, Ramsha Hafeez, Mehnaz Arif, Ayesha Zafar, Mahrukh Gilani, Habiba Ashraf, Sana Rafaqat. Role of Interleukins in Pancreatic Cancer: A Literature Review. Journal of Gastrointestinal Cancer 2024; 55(4) doi: 10.1007/s12029-024-01111-w
|
| 43 |
Ali Amirkhosravi, Sarfraz Ahmad. Immune Therapy for Pancreatic and Colon Cancers. 2025; doi: 10.1016/B978-0-443-24742-2.00027-7
|
| 44 |
Sharon Varghese Thankachan, Vijayalakshmi Jayaraman, Liza Datta, Soniga Apthi, Binish Fatima Zaman, Raghav Gurunathan, Anuppama Suresh, Parthasarathy Chandrakesan, Ramachandran Vinayagam, Sang Gu Kang, Kanagaraj Palaniyandi, Dhanavathy Gnanasampanthapandian. Tumor Microenvironment: Recent Advances in Immunotherapies of Pancreatic Cancer. Medicina 2025; 61(10) doi: 10.3390/medicina61101776
|